Facebook Pixel

FDA Backs Drug That Controls Blood Sugar Via the Brain

Rate This

Type 2 diabetics may soon get another tool to control their blood sugar levels in the form of a drug that resets a body clock in the brain that in turn helps control metabolism, the Associated Press reports.

The U.S. Food and Drug Administration on Wednesday approved Cycloset, made by VeroScience Inc., of Tiverton, R.I., to treat type 2 diabetes. Cycloset, a new version of an older drug called bromocriptine, is used in higher does to treat Parkinson's disease, the drug maker said in a news release, according to the AP. The new drug targets the bodys dopamine activity, a chemical messenger between nerve cells within the nervous system.

Cycloset is the first drug to gain approval under new FDA guidelines requiring better evidence from drug companies that diabetes treatments are heart-safe, since diabetics are at increased risk for cardiovascular problems, the AP reported. The company said Cycloset can be taken once a day in the morning to control post-meal blood sugar rises all during the day.

Add a CommentComments

There are no comments yet. Be the first one and get the conversation started!

Enter the characters shown in the image.
By submitting this form, you agree to EmpowHER's terms of service and privacy policy


Get Email Updates

Diabetes Guide

Have a question? We're here to help. Ask the Community.


Health Newsletter

Receive the latest and greatest in women's health and wellness from EmpowHER - for free!